A Comparative Clinical Study of Palashapushpa and Plaksha twak On its Sangrahi Karma w. s. r. to Shwetapradara
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Change in the clinical symptoms of leucorrhoea
Study Overview
Brief Summary
The Study is a Randomized clinical trial to evaluate the Sangrahi karma of Palasha pushpa churna and Plaksha twak churna on Shwetapradara (leucorrhoea). Total 30 patients will be enrolled in present study. Selected patients will be divided in 2 group on the basis of computer generated randomization. In this study Palasha pushpa churna will be given in dose of 3 gm two times before food with honey for 4 weeks and Plaksha twak churna will be given in dose of 3 gm two times before food with honey for 4 weeks. Folllow up will be **2 weeks.**The clinical data obtained will be summarized at the end of the study. Conclusion will be made after the statistical analysis of the data.
Stastically Palashapushpa churna has significantaly result than Plaksha twak churna.
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Open Label
Eligibility Criteria
- Ages
- 18.00 Year(s) to 50.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Age between 18 to 50 years of female patients.
- •Patient having complaints of Yonigata Shwetasrava.
- •Patients will be selected without consideration of bar of race and religion.
Exclusion Criteria
- •Per vaginal white discharge due to other pathological conditions like- •Cervical or uterine malignancy • Pathological conditions like cervicitis, vaginitis, cervical erosion, PID.
- •Pregnant patient.
- •Uncontrolled systemic Diseases like HTN, DM.
Outcomes
Primary Outcomes
Change in the clinical symptoms of leucorrhoea
Time Frame: 4 weeks
Secondary Outcomes
- Safety(4 weeks)